Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$4M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 9 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 34 most recent Form 4 transactions.
| $1M |
| -51.6% |
| Open the original filing on SEC.gov |
| Aug 7 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 8,000 | $104.38 | $835K | -29.2% | Open the original filing on SEC.gov |
| Aug 7 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 5,000 | $104.47 | $522.4K | -100.0% | Open the original filing on SEC.gov |
| Aug 7 | SYRE | Spyre Therapeutics, Inc. | MEXER◷ | 5,000 | $10.39 | $52K | — | Open the original filing on SEC.gov |
| Jun 24 | KYMR | Kymera Therapeutics, Inc. | AGRANT◆ | 6,068 | — | — | — | Open the original filing on SEC.gov |
| May 27 | SYRE | Spyre Therapeutics, Inc. | AGRANT◆ | 8,026 | — | — | — | Open the original filing on SEC.gov |
| Dec 8, 2025 | KYMR | Kymera Therapeutics, Inc. | MEXER◷◆ | 5,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 8, 2025 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 2,252 | $90.30 | $203.4K | -100.0% | Open the original filing on SEC.gov |
| Dec 8, 2025 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 2,748 | $89.32 | $245.5K | -55.0% | Open the original filing on SEC.gov |
| Dec 8, 2025 | KYMR | Kymera Therapeutics, Inc. | MEXER◷ | 5,000 | $14.18 | $70.9K | — | Open the original filing on SEC.gov |
| Oct 13, 2025 | KYMR | Kymera Therapeutics, Inc. | MEXER◷◆ | 5,000 | — | — | — | Open the original filing on SEC.gov |
| Oct 13, 2025 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 5,000 | $59.19 | $295.9K | -100.0% | Open the original filing on SEC.gov |
| Oct 13, 2025 | KYMR | Kymera Therapeutics, Inc. | MEXER◷ | 5,000 | $10.34 | $51.7K | — | Open the original filing on SEC.gov |
| Jul 17, 2025 | BPMC | Blueprint Medicines Corp | DTOISS◆ | 4,570 | — | — | — | Open the original filing on SEC.gov |
| Jul 17, 2025 | BPMC | Blueprint Medicines Corp | DTOISS◆ | 5,300 | — | — | — | Open the original filing on SEC.gov |
| Jul 17, 2025 | BPMC | Blueprint Medicines Corp | DTOISS◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 17, 2025 | BPMC | Blueprint Medicines Corp | DTOISS◆ | 80,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 17, 2025 | BPMC | Blueprint Medicines Corp | DTOISS◆ | 90,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 17, 2025 | BPMC | Blueprint Medicines Corp | DTOISS◆ | 110,500 | — | — | — | Open the original filing on SEC.gov |
| Jul 17, 2025 | BPMC | Blueprint Medicines Corp | DTOISS◆ | 170,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 17, 2025 | BPMC | Blueprint Medicines Corp | DTOISS◆ | 92,500 | — | — | — | Open the original filing on SEC.gov |
| Jul 17, 2025 | BPMC | Blueprint Medicines Corp | UTENDR | 144,755 | — | — | -100.0% | Open the original filing on SEC.gov |
| Jul 17, 2025 | BPMC | Blueprint Medicines Corp | DTOISS | 5,777 | — | — | -3.8% | Open the original filing on SEC.gov |
| Jun 25, 2025 | KYMR | Kymera Therapeutics, Inc. | AGRANT◆ | 16,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 18, 2025 | BPMC | Blueprint Medicines Corp | AGRANT | 3,902 | $128.12 | $499.9K | +2.7% | Open the original filing on SEC.gov |
| Jun 3, 2025 | KYMR | Kymera Therapeutics, Inc. | MEXER◷◆ | 6,349 | — | — | — | Open the original filing on SEC.gov |
| Jun 3, 2025 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 6,349 | $49.00 | $311.1K | -100.0% | Open the original filing on SEC.gov |
| Jun 3, 2025 | KYMR | Kymera Therapeutics, Inc. | MEXER◷ | 6,349 | $10.34 | $65.6K | — | Open the original filing on SEC.gov |
| May 29, 2025 | SYRE | Spyre Therapeutics, Inc. | AGRANT◆ | 25,000 | — | — | — | Open the original filing on SEC.gov |
| May 27, 2025 | BPMC | Blueprint Medicines Corp | MEXER◷◆ | 5,000 | — | — | — | Open the original filing on SEC.gov |
| May 27, 2025 | BPMC | Blueprint Medicines Corp | SSELL◷ | 650 | $101.93 | $66.3K | -0.4% | Open the original filing on SEC.gov |
| May 27, 2025 | BPMC | Blueprint Medicines Corp | SSELL◷ | 4,350 | $101.02 | $439.4K | -2.9% | Open the original filing on SEC.gov |
| May 27, 2025 | BPMC | Blueprint Medicines Corp | MEXER◷ | 5,000 | $36.05 | $180.3K | +3.4% | Open the original filing on SEC.gov |